# APREMILAST
> **ANDA211761** · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2021-09-21
## Drug
- **FDA Application Number:** ANDA211761
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APREMILAST
- **Generic name:** Apremilast
- **Active ingredients:** APREMILAST
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALKEM LABS LTD
- **First approval:** 2021-09-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211761)
---
*AI Analytics · CC0 1.0*